Literature DB >> 25732646

Invasive, atypical and aggressive pituitary adenomas and carcinomas.

Aydin Sav1, Fabio Rotondo2, Luis V Syro3, Antonio Di Ieva4, Michael D Cusimano4, Kalman Kovacs2.   

Abstract

Aggressive pituitary adenomas have a high risk of recurrence, a lack of therapeutic response, and resistance to conventional treatment. So far, no satisfactory biomarkers are available for predicting their behavior. Some specific pituitary adenoma histotypes are more prone to follow an aggressive behavior. Pituitary carcinomas are rare and show cerebrospinal and/or systemic metastasis. They have worse prognosis than aggressive adenomas, and radiation is of limited use in their treatment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggressive pituitary adenoma; Atypical adenoma; Diagnosis; Invasive adenoma; Noninvasive adenoma; Pituitary carcinoma

Mesh:

Year:  2014        PMID: 25732646     DOI: 10.1016/j.ecl.2014.10.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  23 in total

Review 1.  Management of aggressive growth hormone secreting pituitary adenomas.

Authors:  Daniel A Donoho; Namrata Bose; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 2.  Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Authors:  Nèle Lenders; Ann McCormack
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

3.  Spontaneous Pituitary Adenomas in Squirrel Monkeys (Saimiri sciureus).

Authors:  Gregory J Daggett; Jennifer S Wood; Sanjeev Gumber; Christopher J Pinelli
Journal:  Comp Med       Date:  2019-11-20       Impact factor: 0.982

4.  Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients.

Authors:  A L Pappy; A Savinkina; C Bicknese; S Neill; N M Oyesiku; A G Ioachimescu
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

5.  Surgical Treatment of Cystic Pituitary Prolactin-Secreting Macroadenomas: A Single Center Study of 42 Patients.

Authors:  Xiang Guo; Juan Chen; Zhuo Zhang; Xueyan Wan; Kai Shu; Ting Lei
Journal:  Brain Sci       Date:  2022-05-27

6.  Transcription factor GTF2B regulates AIP protein expression in growth hormone-secreting pituitary adenomas and influences tumor phenotypes.

Authors:  Feng Cai; Shasha Chen; Xuebin Yu; Jing Zhang; Weiwei Liang; Yan Zhang; Yike Chen; Sheng Chen; Yuan Hong; Wei Yan; Wei Wang; Jianmin Zhang; Qun Wu
Journal:  Neuro Oncol       Date:  2022-06-01       Impact factor: 13.029

7.  Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.

Authors:  Kristin Astrid Øystese; Manuela Zucknick; Olivera Casar-Borota; Geir Ringstad; Jens Bollerslev
Journal:  Endocrine       Date:  2017-05-17       Impact factor: 3.633

8.  LOW O6-METHYLGUANINE-DNA METHYTRANSFERASE (MGMT) AND PAN-CYTOKERATIN (PAN-CK) EXPRESSION VIA IMMUNOHISTOCHEMISTRY IN PITUITARY ADENOMAS.

Authors:  R Basaran; M Onoz; F H Bolukbasi; M Efendioglu; A Sav
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

9.  Prolactin-Secreting Pituitary Carcinoma with Dural Metastasis: Diagnosis, Treatment, and Future Directions.

Authors:  Justin Seltzer; John D Carmichael; Deborah Commins; Chia-Shang Jason Liu; Emily Omura; Eric Chang; Gabriel Zada
Journal:  World Neurosurg       Date:  2016-05-06       Impact factor: 2.104

10.  THE EXPRESSION OF STEM CELL MARKERS (CD133, NESTIN, OCT4, SOX2) IN INVASIVE PITUITARY ADENOMAS.

Authors:  R Basaran; D Gundogan; M Senol; C Bozdogan; F Gezen; A Sav
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.